Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D Research In Brief

This article was originally published in The Tan Sheet

Executive Summary

Insufficiency common with osteoporosis: Vitamin D insufficiency is "remarkably common" in pediatric patients with primary and secondary osteopenia or osteoporosis, according to a study in the June Pediatrics journal. Researchers led by Sasigarn A. Bowden, of the endocrinology and nephrology divisions at Columbus (Ohio) Children's Hospital/Ohio State University College of Medicine, monitored serum 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D - the physically active form of the vitamin - parathyroid hormone and other bone markers, as well as bone mineral density, in 85 pediatric patients with primary osteoporosis and secondary osteopenia. They found vitamin D insufficiency - defined as serum 25-OH D at less than 30 nanograms per milliliter - in 80 percent of the patients, while overt vitamin D deficiency - 25-OH D at less than 10 ng/ml - was present in 3.5 percent. The researchers also found an inverse relationship between 25-OH D and parathyroid hormone levels, which suggests a "physiologic impact of insufficient vitamin D levels that may contribute to low bone mass or worsen the primary bone disease." Bowden et al. suggest monitoring and supplementation with vitamin D should be a priority...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101754

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel